Zinzino acquires health-focused direct seller Uzesta, adding 4 mUSD in annual revenue and leveraging regional offices in Kuala Lumpur and Taipei to accelerate APAC growth.
Zinzino announced on Nov. 11, 2026 the asset acquisition of Uzesta, a direct-selling health company with roughly 4 mUSD annual revenue, for 0.8 mUSD cash plus 0.4 mUSD deferred and up to 6.0 mUSD in performance-based additional price. The deal expands APAC distribution using existing offices in Kuala Lumpur and Taipei, but the target's size is small relative to the group and 91% of the earnout is settled in new shares, which dilutes existing holders. The quantified terms support a mildly positive read, but modest deal scale limits the price effect.
Zinzino AB announced the acquisition of Uzesta Global LLC on Nov. 11, 2026, to bolster its presence in Taiwan, Hong Kong, Thailand, and Malaysia. The deal includes a 0.8 mUSD cash payment and 0.4 mUSD deferred, with potential performance-based earn-outs of up to 6.0 mUSD, 91% of which will be settled in new Zinzino shares.
A fixed 0.8 mUSD in cash at closing, plus a deferred 0.4 mUSD, and additional purchase prices tied to future sales that could reach 6.0 mUSD in the best case; 91% of that additional price is paid in new Zinzino shares.
Uzesta generates total annual revenue of approximately 4 mUSD and operates in Taiwan, Malaysia, Hong Kong and Thailand.